CoChat

Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study

Open access
Kang, Sung-Woo, An, Min Ho, Ha, Seojung, Kim, Min-Gyu, Park, Tae Jun, Kim, Han Ki, Sheen, Kisung, Park, Rae Woong, Park, Soon Sang · 2024 · Scientific Reports

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 58 sources its claims cite is checked for support yet.

Abstract

Gastroesophageal Reflux Disease (GERD) is characterized by the regurgitation of stomach contents. Recent research indicates that acid reflux may disrupt the homeostasis of the middle and inner ear through the Eustachian tube. Given this context, we hypothesized that an association between GERD and tinnitus may exist due to the imbalance of the middle and inner ear caused by acid reflux. To explore this connection, we conducted a retrospective cohort study involving 669,159 patients registered in the National Health Insurance Service-National Sample Cohort (2012-2019) in South Korea. Our data showed that GERD and tinnitus are highly associated. Nevertheless, the use of proton pump inhibitor medication in GERD patients did not show a significant decrease in the onset of tinnitus.

Overview

CoChat Summary

TL;DR

In a nationwide South Korean retrospective cohort, GERD was associated with a markedly higher incidence of tinnitus, and among GERD patients PPI use was associated with higher rather than lower tinnitus risk. Sensitivity analyses with lag periods and a stricter tinnitus definition were consistent with the main results.

Key findings

  • GERD exposure was associated with increased tinnitus incidence: 14.91 vs 1.74 cases per 1000 person-years (GERD vs non-GERD); crude HR 8.32 (95% CI 8.12–8.52), adjusted HR 7.15 (95% CI 6.99–7.32), and medication-adjusted HR 6.65 (95% CI 6.50–6.81).
  • Among GERD patients, PPI exposure was associated with increased tinnitus incidence: 17.22 vs 10.80 cases per 1000 person-years (PPI vs non-PPI); crude HR 1.54 (95% CI 1.51–1.57), Model 1 aHR 1.40 (95% CI 1.38–1.43), and Model 2 aHR 1.35 (95% CI 1.32–1.38).
  • Sensitivity analyses remained consistent: for GERD, HRs ranged from 4.01 in the fully adjusted 730-day lag model to 10.28 in the crude analysis requiring two tinnitus diagnoses; for PPI, HRs ranged from 1.12 in the fully adjusted 730-day lag model to 1.62 in the crude two-diagnosis analysis.

Methods

  • Retrospective nationwide population-based cohort study using the Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC 2.2, 2002–2019); primary analysis included GERD patients diagnosed by ICD-10 K21 and subcodes and a non-GERD comparator, with tinnitus outcome defined by ICD-10 H93.1.
  • Adults aged 18 or older at index date were included; exclusions included tinnitus or GERD diagnosis in 2002, tinnitus diagnosis or death before GERD diagnosis, and for the secondary analysis additional exclusions related to prior tinnitus, PPI use, or death before PPI use.
  • Cox proportional hazards models estimated hazard ratios with 95% CIs; Kaplan–Meier curves and log-rank tests compared cumulative incidence; covariates included age, sex, income, comorbidities, medications, number of gastroendoscopies and visits, and Charlson Comorbidity Index; sensitivity analyses used 180-, 365-, and 730-day lag times and a second tinnitus diagnosis.

Limitations

  • The paper states that as a retrospective observational study using health claim data, there may be unmeasured covariates, and GERD severity or diagnostic results may be difficult to ascertain; it also notes that mental health codes were often masked, so antidepressants and benzodiazepines were used as proxies.
  • The paper states possible surveillance bias, differences in severity, and variations in health-seeking behavior between groups, and that detailed hearing-related data such as tone audiogram results were unavailable.
  • Evident from the text: the observational design cannot establish causality, and residual confounding or confounding by indication may affect the PPI analysis; the GERD definition was previously validated with 74% diagnostic accuracy, and the abstract’s “669,159 patients” differs from the results’ reported cohort counts.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41598-024-81658-7

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 A flowchart of the primary analysis. A flow chart illustrates the overall process of primary analysis before and after applying inclusion and exclusion criteria. GERD: Gastroesophageal reflux disease. National Health Insurance Service-National Sample Cohort (NHIS-NSC).
Fig. 1 A flowchart of the primary analysis. A flow chart illustrates the overall process of primary analysis before and after applying inclusion and exclusion criteria. GERD: Gastroesophageal reflux disease. National Health Insurance Service-National Sample Cohort (NHIS-NSC).CC BY-NC-ND · PubMed Central
Fig. 2 The cumulative incidence of tinnitus in patients with or without GERD. A Kaplan–Meier curve illustrates the cumulative incidence of tinnitus in patients with or without GERD. GERD: Gastroesophageal reflux disease.
Fig. 2 The cumulative incidence of tinnitus in patients with or without GERD. A Kaplan–Meier curve illustrates the cumulative incidence of tinnitus in patients with or without GERD. GERD: Gastroesophageal reflux disease.CC BY-NC-ND · PubMed Central
Fig. 3 Forest plots from primary analysis using multivariate Cox regression (model 2). CCB: calcium channel blocker; CCI: Charlson Comorbidity Index; CI: confidence interval; GERD: gastroesophageal reflux disease; H2RA: H2 receptor antagonist; PPI: proton pump inhibitor.
Fig. 3 Forest plots from primary analysis using multivariate Cox regression (model 2). CCB: calcium channel blocker; CCI: Charlson Comorbidity Index; CI: confidence interval; GERD: gastroesophageal reflux disease; H2RA: H2 receptor antagonist; PPI: proton pump inhibitor.CC BY-NC-ND · PubMed Central
Fig. 4 A flowchart of the secondary analysis. A flow chart illustrates the overall process of secondary analysis before and after applying inclusion and exclusion criteria. GERD: Gastroesophageal reflux disease; National Health Insurance Service-National Sample Cohort (NHIS-NSC); PPI: Proton pump inhibitor.
Fig. 4 A flowchart of the secondary analysis. A flow chart illustrates the overall process of secondary analysis before and after applying inclusion and exclusion criteria. GERD: Gastroesophageal reflux disease; National Health Insurance Service-National Sample Cohort (NHIS-NSC); PPI: Proton pump inhibitor.CC BY-NC-ND · PubMed Central
Fig. 5 The cumulative incidence of tinnitus in patients with or without PPIs. A Kaplan–Meier curve illustrates the cumulative incidence of tinnitus in patients with or without PPIs. PPI: proton pump inhibitor.
Fig. 5 The cumulative incidence of tinnitus in patients with or without PPIs. A Kaplan–Meier curve illustrates the cumulative incidence of tinnitus in patients with or without PPIs. PPI: proton pump inhibitor.CC BY-NC-ND · PubMed Central
Fig. 6 Forest plots from secondary analysis using multivariate Cox regression (model 2). CCB: calcium channel blocker; CCI: Charlson Comorbidity Index; CI: confidence interval; H2RA: H2 receptor antagonist; PPI: proton pump inhibitor.
Fig. 6 Forest plots from secondary analysis using multivariate Cox regression (model 2). CCB: calcium channel blocker; CCI: Charlson Comorbidity Index; CI: confidence interval; H2RA: H2 receptor antagonist; PPI: proton pump inhibitor.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 35 Not checked · 37 Own results and interpretations

18 more claims

Create a free account to see all 72 claims and to verify the 58 references still open.

See all claims — free account
  • The quote only partly states this claim. 4
  • It may state two separate claims as one. 22
  • Probably not a substantial claim. 35

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 40 references

Cited by

See all 4

Metadata

Authors
Kang, S.-W., An, M. H., Ha, S., Kim, M.-G., Park, T. J., Kim, H. K., Sheen, K., Park, R. W., & Park, S. S.
Affiliations
  • Kyung Hee University (KR)
  • Ajou University (KR)
  • Sangji University (KR)
  • Ajou University Medical Center (KR)
Corresponding author
Park, Soon Sang
Venue
Scientific Reports
Published
2024-12-03
Volume
14
Issue
1
Pages
30106-30106
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4404963404
Cited by
4
References
40
Citations by year
2026: 2 · 2025: 2
FWCI
0.85
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • AJOU Open Repository (Ajou University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ajou University Hospital
  • National Research Foundation of Korea (NRF-2020M3A9D8037604)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Otorhinolaryngology › Ear Surgery and Otitis Media
Keywords
gastroesophageal reflux disease, tinnitus, gastroesophageal reflux, Eustachian tube, middle ear, inner ear, proton pump inhibitors
MeSH terms
Adult, Aged, Female, Gastroesophageal Reflux, Humans, Male, Middle Aged, Retrospective Studies, Tinnitus, Cohort Studies, Proton Pump Inhibitors, Republic of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study. https://app.cochat.ai/papers/10.1038/s41598-024-81658-7
The paper
Kang, S.-W., An, M. H., Ha, S., Kim, M.-G., Park, T. J., Kim, H. K., Sheen, K., Park, R. W., & Park, S. S. (2024). Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study. Scientific Reports. https://doi.org/10.1038/s41598-024-81658-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.